Transgenic MSH overexpression attenuates the metabolic effects of a high-fat diet
Open Access
- 1 July 2007
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 293 (1), E121-E131
- https://doi.org/10.1152/ajpendo.00555.2006
Abstract
To determine whether long-term melanocortinergic activation can attenuate the metabolic effects of a high fat diet, mice overexpressing an NH2-terminal POMC transgene that includes α- and γ3-MSH were studied on either a 10% low-fat diet (LFD) or 45% high-fat diet (HFD). Weight gain was modestly reduced in transgenic (Tg-MSH) male and female mice vs. wild type (WT) on HFD ( P < 0.05) but not LFD. Substantial reductions in body fat percentage were found in both male and female Tg-MSH mice on LFD ( P < 0.05) and were more pronounced on HFD ( P < 0.001). These changes occurred in the absence of significant feeding differences in most groups, consistent with effects of Tg-MSH on energy expenditure and partitioning. This is supported by indirect calorimetry studies demonstrating higher resting oxygen consumption and lower RQ in Tg-MSH mice on the HFD. Tg-MSH mice had lower fasting insulin levels and improved glucose tolerance on both diets. Histological and biochemical analyses revealed that hepatic fat accumulation was markedly reduced in Tg-MSH mice on the HFD. Tg-MSH also attenuated the increase in corticosterone induced by the HFD. Higher levels of Agrp mRNA, which might counteract effects of the transgene, were measured in Tg-MSH mice on LFD ( P = 0.02) but not HFD. These data show that long-term melanocortin activation reduces body weight, adiposity, and hepatic fat accumulation and improves glucose metabolism, particularly in the setting of diet-induced obesity. Our results suggest that long-term melanocortinergic activation could serve as a potential strategy for the treatment of obesity and its deleterious metabolic consequences.Keywords
This publication has 66 references indexed in Scilit:
- The melanocortin system and energy balancePeptides, 2006
- Glucocorticoids exacerbate obesity and insulin resistance in neuron-specific proopiomelanocortin-deficient miceJCI Insight, 2006
- Anatomy and regulation of the central melanocortin systemNature Neuroscience, 2005
- Characterization of the resistance to the anorectic and endocrine effects of leptin in obesity-prone and obesity-resistant rats fed a high-fat dietJournal of Endocrinology, 2004
- Melanocortin-independent Effects of Leptin on Hepatic Glucose FluxesJournal of Biological Chemistry, 2004
- Assessment of the aversive consequences of acute and chronic administration of the melanocortin agonist, MTIIInternational Journal of Obesity, 2003
- The Leptin-Like Effects of 3-d Peripheral Administration of a Melanocortin Agonist Are More Marked in Genetically Obese Zucker (fa/fa) than in Lean RatsEndocrinology, 2002
- Integration of NPY, AGRP, and Melanocortin Signals in the Hypothalamic Paraventricular NucleusNeuron, 1999
- Agouti-Related Protein Containing Nerve Terminals Innervate Thyrotropin-Releasing Hormone Neurons in the Hypothalamic Paraventricular NucleusEndocrinology, 1999
- Central administration of α-melanocyte-stimulating hormone inhibits corticotropin-releasing factor release in adrenalectomized ratsNeuroscience Letters, 1994